Danaher Announces Acquisition of Masimo for $9.9 Billion

Danaher Corporation has announced the acquisition of Masimo Corporation in a deal valued at approximately $9.9 billion. The transaction is seen as part of Danaher's strategy to expand its health technology portfolio. The acquisition aims to combine Masimo's expertise in patient monitoring and medical device technologies with Danaher's operational capabilities. Under the terms of the agreement, Danaher acquired all outstanding shares of Masimo for cash. This move aligns with Danaher's previously announced growth plans. Company officials stated that Masimo's existing management team will continue to lead operations following the completion of the acquisition. Masimo is particularly known for its pulse oximetry and other non-invasive monitoring technologies. Through this acquisition, Danaher aims to strengthen its presence in the healthcare sector and deliver innovative solutions in patient care. The transaction is expected to provide significant benefits to both companies' existing customer bases and product portfolios. From a financial perspective, the $9.9 billion acquisition was financed using Danaher's cash flow and borrowing capacity. The company anticipates that this investment will create long-term shareholder value. Analysts believe the deal could accelerate Danaher's growth rate and enhance its competitive position in the health technology market. This is not investment advice.